Schrama D - Search Results

1

Antibody-Drug Conjugates as an Emerging Therapy in Oncodermatology.

Esnault C, Schrama D, Houben R, Guyétant S, Desgranges A, Martin C, Berthon P, Viaud-Massuard MC, Touzé A, Kervarrec T, Samimi M. Esnault C, et al. Among authors: schrama d. Cancers (Basel). 2022 Feb 2;14(3):778. doi: 10.3390/cancers14030778. Cancers (Basel). 2022. PMID: 35159045 Free PMC article. Review.

2

[Kinase inhibitors for the therapy of malignant melanoma].

Becker JC, Schrama D, Bröcker EB, Houben R. Becker JC, et al. Among authors: schrama d. J Dtsch Dermatol Ges. 2005 Oct;3(10):762-7. doi: 10.1111/j.1610-0387.2005.05016.x. J Dtsch Dermatol Ges. 2005. PMID: 16194153 Review. German.

3

[New therapeutic approaches for solid tumors: histone deacetylase, methyltransferase and proteasome inhibitors].

Becker JC, Ugurel S, Bröcker EB, Schrama D, Houben R. Becker JC, et al. Among authors: schrama d. J Dtsch Dermatol Ges. 2006 Feb;4(2):108-13. doi: 10.1111/j.1610-0387.2006.05920.x. J Dtsch Dermatol Ges. 2006. PMID: 16503937 German.

4

Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.

Wobser M, Voigt H, Houben R, Eggert AO, Freiwald M, Kaemmerer U, Kaempgen E, Schrama D, Becker JC. Wobser M, et al. Among authors: schrama d. Cancer Immunol Immunother. 2007 Jul;56(7):1017-24. doi: 10.1007/s00262-006-0256-1. Epub 2006 Dec 29. Cancer Immunol Immunother. 2007. PMID: 17195079 Free PMC article.

5

Activation of the MAP kinase pathway induces apoptosis in the Merkel cell carcinoma cell line UISO.

Houben R, Ortmann S, Schrama D, Herold MJ, Berberich I, Reichardt HM, Becker JC. Houben R, et al. Among authors: schrama d. J Invest Dermatol. 2007 Sep;127(9):2116-22. doi: 10.1038/sj.jid.5700857. Epub 2007 May 3. J Invest Dermatol. 2007. PMID: 17476292 Free article.

6

Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma.

Voigt H, Houben R, Schrama D, Hofmann UB, Vetter-Kauczok CS, Becker JC. Voigt H, et al. Among authors: schrama d. Tumour Biol. 2007;28(4):229-37. doi: 10.1159/000107418. Epub 2007 Aug 20. Tumour Biol. 2007. PMID: 17709990

7

Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy.

Ugurel S, Schrama D, Keller G, Schadendorf D, Bröcker EB, Houben R, Zapatka M, Fink W, Kaufman HL, Becker JC. Ugurel S, et al. Among authors: schrama d. Cancer Immunol Immunother. 2008 May;57(5):685-91. doi: 10.1007/s00262-007-0407-z. Epub 2007 Oct 2. Cancer Immunol Immunother. 2008. PMID: 17909797 Free PMC article.

8

Melanoma stem cells: targets for successful therapy?

Houben R, Wischhusen J, Menaa F, Synwoldt P, Schrama D, Bröcker EB, Becker JC. Houben R, et al. Among authors: schrama d. J Dtsch Dermatol Ges. 2008 Jul;6(7):541-6. doi: 10.1111/j.1610-0387.2008.06786.x. Epub 2008 May 30. J Dtsch Dermatol Ges. 2008. PMID: 18513214 Review. English, German.

9

BRAFV600E mutations in malignant melanoma are associated with increased expressions of BAALC.

Schrama D, Keller G, Houben R, Ziegler CG, Vetter-Kauczok CS, Ugurel S, Becker JC. Schrama D, et al. J Carcinog. 2008 Jul 16;7:1. doi: 10.1186/1477-3163-7-1. J Carcinog. 2008. PMID: 18631381 Free PMC article.

10

Merkel cell carcinoma.

Becker JC, Schrama D, Houben R. Becker JC, et al. Among authors: schrama d. Cell Mol Life Sci. 2009 Jan;66(1):1-8. doi: 10.1007/s00018-008-8483-6. Cell Mol Life Sci. 2009. PMID: 19023519 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page